HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Phil Lieberman Selected Research

Vasomotor Rhinitis

3/2014Long-term, randomized safety study of MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) in subjects with chronic rhinitis.
3/2011Two-week comparison study of olopatadine hydrochloride nasal spray 0.6% versus azelastine hydrochloride nasal spray 0.1% in patients with vasomotor rhinitis.
8/2009The role of antihistamines in the treatment of vasomotor rhinitis.
4/2005Open-label evaluation of azelastine nasal spray in patients with seasonal allergic rhinitis and nonallergic vasomotor rhinitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Phil Lieberman Research Topics

Disease

12Anaphylaxis (Anaphylactic Shock)
01/2020 - 08/2002
6Allergic Rhinitis
04/2015 - 02/2011
5Hypersensitivity (Allergy)
01/2019 - 04/2006
5Seasonal Allergic Rhinitis (Hay Fever)
04/2015 - 04/2005
5Asthma (Bronchial Asthma)
01/2015 - 04/2006
5Rhinitis
06/2014 - 04/2005
4Vasomotor Rhinitis
03/2014 - 04/2005
2Food Hypersensitivity (Food Allergy)
01/2019 - 12/2010
1Colitis
01/2020
1Heart Diseases (Heart Disease)
01/2019
1Insect Bites and Stings (Insect Bite)
01/2019
1Obesity
01/2016
1Perennial Allergic Rhinitis
04/2015
1Vomiting
01/2014
1Urticaria (Hives)
07/2012
1Coronary Artery Disease (Coronary Atherosclerosis)
07/2012
1Angioedema
07/2012
1Obstructive Lung Diseases (Obstructive Lung Disease)
10/2010
1Pathologic Processes
10/2010
1Eosinophilia
09/2007
1Immediate Hypersensitivity
05/2007
1Laryngeal Edema
09/2005
1Hypotension (Low Blood Pressure)
09/2005
1Latex Hypersensitivity (Latex Allergy)
08/2002
1Genetic Predisposition to Disease (Genetic Predisposition)
08/2002

Drug/Important Bio-Agent (IBA)

8Epinephrine (Adrenaline)FDA LinkGeneric
01/2020 - 08/2003
6azelastine (Optivar)FDA LinkGeneric
04/2015 - 04/2005
5Histamine Antagonists (Antihistamines)IBA
01/2020 - 08/2002
4Adrenal Cortex Hormones (Corticosteroids)IBA
08/2015 - 08/2002
4Fluticasone (Cutivate)FDA LinkGeneric
04/2015 - 05/2012
3AntigensIBA
03/2017 - 09/2005
3Immunoglobulin E (IgE)IBA
03/2017 - 12/2010
3MP29-02IBA
04/2015 - 05/2012
2Pharmaceutical PreparationsIBA
01/2016 - 11/2012
2AllergensIBA
01/2015 - 12/2010
2Nasal SpraysIBA
03/2011 - 04/2005
1GlucocorticoidsIBA
01/2020
1Tryptases (Tryptase)IBA
01/2020
1Contrast MediaIBA
01/2020
1TitaniumIBA
12/2018
1TabletsIBA
12/2018
1Oxygen (Dioxygen)IBA
01/2014
1Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
07/2012
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
07/2012
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
07/2012
1Olopatadine Hydrochloride (Patanol)FDA Link
03/2011
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
02/2011
1Histamine (Histamine Dihydrochloride)FDA Link
02/2011
1Anti-Allergic Agents (Antiallergic Agents)IBA
08/2009
1Nitric Oxide (Nitrogen Monoxide)FDA Link
09/2007
1Omalizumab (Xolair)FDA Link
05/2007
1Non-Sedating Histamine H1 Antagonists (Histamine H1 Antagonists, Non Sedating)IBA
04/2005
1LatexIBA
08/2002

Therapy/Procedure

8Therapeutics
08/2015 - 08/2003
2Immunotherapy
01/2020 - 11/2012
2Drug Therapy (Chemotherapy)
01/2020 - 04/2015
1Premedication
01/2020
1Injections
01/2020
1Polypharmacy
01/2019
1Intramuscular Injections
01/2014
1Cardiopulmonary Resuscitation (CPR)
01/2014
1Resuscitation
01/2014
1Operative Surgical Procedures
08/2002
1Anesthesia
08/2002
1Catheters
08/2002
1Indwelling Catheters (Indwelling Catheter)
08/2002